Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Understand how zero based budgeting allows for flexibility and necessary adjustments to meet changing financial needs.
28,655 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A nuclear stock down 46% this year may look tempting, but ambition must be balanced with diligence. This guide breaks...
Bitcoin selling pressure weakens as a surge in U.S. spot ETF inflows shows renewed demand. This article breaks down w...
Hongkong Land is reinventing itself after more than a century, shifting from Hong Kong-centric rents to a broader Asi...
Sea Limited faced a challenging year with its shares down significantly. A top executive sold a chunk of stock, promp...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
The idea of a bargain in the cruise sector is enticing, but cheap can be risky. This article breaks down how to judge...
A powerful stock rebound in META reshaped fortunes and sparked a closer look at risk, diversification, and wealth dyn...
Global security priorities and rising defense budgets spotlight the best aerospace defense stocks. Here’s a timely lo...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
Palantir faces a pivotal investor update that could move the stock. This guide breaks down the risks, catalysts, and ...
NEAR token surged recently, signaling renewed market interest. This guide unpacks the drivers behind the near protoco...